Allergy Therapeutics
AGY.L
#6539
Rank
C$1.09 B
Marketcap
C$0.17
Share price
2.78%
Change (1 day)
25.34%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2025: -C$74.35 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are C$75.57 Million. In 2025 the company made an earning of -C$74.35 Million a decrease over its 2024 earnings that were of -C$68.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025-C$74.35 Million8.65%
2024-C$68.43 Million-6.69%
2023-C$73.34 Million244.94%
2022-C$21.27 Million-404.35%
2021C$6.98 M-49.42%
2020C$13.81 M83.48%
2019C$7.52 M-159.83%
2018-C$12.59 Million255.48%
2017-C$3.54 Million-84.06%
2016-C$22.22 Million-1667.33%
2015C$1.41 M-44.68%
2014C$2.56 M130.59%
2013C$1.11 M-19.89%
2012C$1.38 M-127.05%
2011-C$5.13 Million2009.96%
2010-C$0.25 Million-99.07%
2009-C$26.04 Million-53.23%
2008-C$55.66 Million-21.86%
2007-C$71.24 Million356.94%
2006-C$15.59 Million230.75%
2005-C$4.72 Million-217.9%
2004C$3.99 M-58.79%
2003C$9.7 M-196.03%
2002-C$10.11 Million